Access to healthcare
Home / Sustainability / Access to healthcare
Our approach to Access to healthcare
Science can deliver progress for us all
We are committed to supporting society through some of its toughest healthcare challenges. We work in collaboration with governments, academia, international and local organisations, and other stakeholders, and we always put patients first. Our response to the COVID-19 pandemic, with a focus on low and middle-income countries, was one example of our equitable access strategy in action.
We provide healthcare solutions across the patient care pathway — from prevention, raising awareness, diagnosis and treatment, to post-treatment support.
Our focus areas
Equitable access
Embedding practices into our product portfolio to drive equitable access to healthcare — including digital health, clinical trial diversity, patient centricity, investment in rare diseases, open innovation and IP-sharing arrangements.
Affordability and pricing
Drive accessibility of medicines for diverse, equitable and inclusive patient groups, through company policy and programming, including core pricing principles and access programmes
Health system resilience
Strengthen health systems through advocacy, build capabilities to address unmet medical need, improve access to quality healthcare, and provide solutions along a care continuum from prevention to post-treatment; commit to disaster relief, grants and donations.
Our ambition by 2025:
Reach 50 million
Train 170,000
Increase collaboration
Our achievements
>44.63 million
126,684
>12.83 million
*as at end December 2022. Source: Sustainability Report
Our highlights
Young Health Programme
Since 2010, our Young Health Programme has worked to empower young people aged 10-24 to manage their health, to help prevent long-term conditions like cancer, diabetes, respiratory and heart diseases – often called non-communicable diseases. Through community programmes, research, advocacy and developing generations of young leaders, we are supporting young people make better health choices for brighter life chances.
Partnership for Health System Sustainability and Resilience
This collaboration between the London School of Economics, the World Economic Forum and AstraZeneca continued its work to strengthen global health systems, now active in over 30 countries worldwide.
Healthy Heart Africa
Our Healthy Heart Africa programme is committed to tackling hypertension and the increasing burden of cardiovascular disease across Africa. We are committed to reaching 10 million people with elevated blood pressure across Africa by 2025, working with local and global partners to train providers, increase education and awareness, and facilitate access to low-cost anti-hypertensives where applicable.
